[Chungsan News Reporter Kim Young-gil] Central Vaccine Institute and Comepipharm obtain 'export' item approval...Boost for overseas market development Clinical trial nearing completion 'Confirmed excellent safety and efficacy'...Expectations for 'global prevention' Overseas or domestic BSL3 production plans...Support from prevention authorities, administrative and institutional A domestic African swine fever (ASF) vaccine has taken one step closer to export. On April 15 and 16, the Central Vaccine Institute and Comepipharm respectively obtained 'export' item approval for their developed ASF vaccines. When exporting animal drugs, the importing country requires domestic animal drug item approval (including 'export') as one of the essential requirements. Having secured this important approval, the overseas market development of the ASF vaccine is expected to receive a boost. However, if they plan to release the vaccine domestically in the future, they will need to obtain domestic ...